Subscribe To
Cellectar Biosciences Expands Global Intellectual Property Portfolio with Four Patent Grants

FLORHAM PARK, N.J., Oct. 02, 2023 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announced significant advancements to its global intellectual property (IP) portfolio. Cellectar has secured four patents across the key global regions […] The post Cellectar Biosciences Expands Global Intellectual Property Portfolio with Fou...
Read More
Content Topics
Cellectar
Biosciences
Expands
Global
Intellectual
Property
Portfolio
Patent
Grants
Forex
Posted: Oct 2 2023, 10:35
Author Name: forextv
Views: 082929